Harel Insurance Investments & Financial Services Ltd. Kamada LTD Call Options Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

Call Options

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

Others Institutions Holding KMDA

# of Institutions

Shares Held

6.48M

Call Options Held

200

Put Options Held

Phoenix Holdings Ltd. Givatayim, L3

1.83M
Shares

$11.1 Million
0.15% of portfolio
Vanguard Group Inc Valley Forge, PA

1.38M
Shares

$8.38 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

856K
Shares

$5.18 Million
0.01% of portfolio
Y.D. More Investments LTD Ramat Gan, L3

710K
Shares

$4.29 Million
0.4% of portfolio
Wells Fargo & Company San Francisco, CA

630K
Shares

$3.81 Million
0.0% of portfolio

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $271M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account